blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2611913

EP2611913 - BACTERIOPHAGE LYTIC ENZYMES AS ALTERNATIVE ANTIMICROBIALS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.11.2014
Database last updated on 12.07.2024
Most recent event   Tooltip21.11.2014Application deemed to be withdrawnpublished on 24.12.2014  [2014/52]
Applicant(s)For all designated states
The United States of America as represented by the secretary of Agriculture
Washington, DC 20250-1400 / US
[2013/28]
Inventor(s)01 / SEAL, Bruce, S.
137 Buttonwood Loop
Athens, GA 30605 / US
02 / SIRAGUSA, Gregory, R.
2915 Cone View Lane
Waukesha, WI 53188 / US
03 / SIMMONS, Ibn, Mustafa, A.
950 College Station Road
Athens, GA 30605 / US
04 / GARRISH, Johnna, K.
950 College Station Road
Athens, GA 30605 / US
05 / DONOVAN, David, M.
2502 Island View Road
Baltimore, MD 21221 / US
 [2013/28]
Representative(s)Michalski Hüttermann & Partner Patentanwälte mbB
Kaistraße 16A
40221 Düsseldorf / DE
[N/P]
Former [2013/28]Michalski Hüttermann & Partner Patentanwälte
Hafenspitze
Speditionstrasse 21
40221 Düsseldorf / DE
Application number, filing date11822347.817.08.2011
WO2011US48054
Priority number, dateUS2010087413801.09.2010         Original published format: US 874138
[2013/28]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2012030535
Date:08.03.2012
Language:EN
[2012/10]
Type: A2 Application without search report 
No.:EP2611913
Date:10.07.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 08.03.2012 takes the place of the publication of the European patent application.
[2013/28]
Search report(s)International search report - published on:KR31.05.2012
(Supplementary) European search report - dispatched on:EP29.11.2013
ClassificationIPC:C12N9/36, C12N15/56, A61K38/47, A61P31/04, A23K1/165, C12R1/145
[2013/28]
CPC:
C12N9/80 (EP,US); A23K20/189 (EP,US); A23K50/75 (EP,US);
A61P31/04 (EP); C12Y305/01028 (EP,US); C12N2795/10321 (EP,US);
C12N2795/10322 (EP,US); C12N2795/10332 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/28]
TitleGerman:BAKTERIOPHAGEN-LÖSENDE ENZYME ALS ALTERNATIVE ANTIMIKROBIELLE MITTEL[2013/28]
English:BACTERIOPHAGE LYTIC ENZYMES AS ALTERNATIVE ANTIMICROBIALS[2013/28]
French:ENZYMES LYTIQUES DE BACTÉRIOPHAGES, EN TANT QU'AGENTS ANTIMICROBIENS DE REMPLACEMENT[2013/28]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase26.03.2013National basic fee paid 
26.03.2013Search fee paid 
26.03.2013Designation fee(s) paid 
26.03.2013Examination fee paid 
Examination procedure26.03.2013Examination requested  [2013/28]
17.10.2013Amendment by applicant (claims and/or description)
28.06.2014Application deemed to be withdrawn, date of legal effect  [2014/52]
05.08.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time  [2014/52]
Fees paidRenewal fee
27.08.2013Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.08.201404   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]  - UniParc, (20100205), Database accession no. UPI0002048BD0, XP002716382 [X] 1,2,4-6 * the whole document * [I] 7,8,10-15
 [XI]  - UniParc, (20081002), Database accession no. UPI000181BCFB, XP002716383 [X] 1,3-6 * the whole document * [I] 7,9-15
 [A]  - ZIMMER MARKUS ET AL, "The murein hydrolase of the bacteriophage phi3626 dual lysis system is active against all tested Clostridium perfringens strains", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, (20021101), vol. 68, no. 11, doi:10.1128/AEM.68.7.3293-3299.2002, ISSN 0099-2240, pages 5311 - 5317, XP002246439 [A] 1 * page 5311 * * abstract *

DOI:   http://dx.doi.org/10.1128/AEM.68.7.3293-3299.2002
 [XP]  - MUSTAFA SIMMONS ET AL, "Recombinant Expression of Two Bacteriophage Proteins That Lyse Clostridium perfringens and Share Identical Sequences in the C-Terminal Cell Wall Binding Domain of the Molecules but Are Dissimilar in Their N-Terminal Active Domains", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, (20101013), vol. 58, no. 19, doi:10.1021/jf101387v, ISSN 0021-8561, pages 10330 - 10337, XP055081674 [XP] 13-15 * the whole document *

DOI:   http://dx.doi.org/10.1021/jf101387v
 [AP]  - SEAL BRUCE S ET AL, "Clostridium perfringens bacteriophages Phi CP39Oand Phi CP26F: genomic organization and proteomic analysis of the virions", ARCHIVES OF VIROLOGY, (201101), vol. 156, no. 1, pages 25 - 35, XP002716384 [AP] 1 * page 25 * * abstract *

DOI:   http://dx.doi.org/10.1007/s00705-010-0812-z
International search[A]EP0510907  (AGRICULTURAL & FOOD RES [GB]);
 [Y]  - LOESSNER M.J. ET AL., "Bacteriophage endolysins - current state of research and applications", CURRENT OPINION IN MICROBIOLOGY, (200508), vol. 8, no. 4, pages 480 - 487, XP027848308
 [X]  - "Amidase-hydrolase [Clostridium phage 39-O]", GENPEPT, (20081003), Database accession no. YP_002265435, XP003031831
 [A]  - BORYSOWSKI J. ET AL., "Bacteriophage endolysins as a novel class of antibacterial agents", EXPERIMENTAL BIOLOGY AND MEDICINE, (200604), vol. 231, no. 4, pages 366 - 377, XP002449938
 [A]  - ZIMMER M. ET AL., "The murein hydrolase of the bacteriophage phi3626 dual lysis system is active against all tested Clostridium perfringens strains", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, (200211), vol. 68, no. 11, pages 5311 - 5317, XP002246439

DOI:   http://dx.doi.org/10.1128/AEM.68.7.3293-3299.2002
 [XP]  - SIMMONS M. ET AL., "Recombinant expression of two bacteriophage proteins that lyse clostridium perfringens and share identical sequences in the C-terminal cell wall binding domain of the molecules but are dissimilar in their N-rerminal active domains", JOURNAL OF AGRICULTURE AND FOOD CHEMISTRY, (20101013), vol. 58, no. 19, pages 10330 - 10337, XP055081674

DOI:   http://dx.doi.org/10.1021/jf101387v
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.